annual FCF:
$10.83B+$3.41B(+45.91%)Summary
- As of today (April 16, 2025), GILD annual free cash flow is $10.83 billion, with the most recent change of +$3.41 billion (+45.91%) on December 31, 2024.
- During the last 3 years, GILD annual FCF has risen by +$23.00 million (+0.21%).
- GILD annual FCF is now -47.19% below its all-time high of $20.50 billion, reached on December 31, 2015.
Performance
GILD Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$2.83B-$1.34B(-32.15%)Summary
- As of today (April 16, 2025), GILD quarterly free cash flow is $2.83 billion, with the most recent change of -$1.34 billion (-32.15%) on December 31, 2024.
- Over the past year, GILD quarterly FCF has dropped by -$1.34 billion (-32.15%).
- GILD quarterly FCF is now -49.76% below its all-time high of $5.63 billion, reached on December 31, 2015.
Performance
GILD quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$10.30B+$874.00M(+9.27%)Summary
- As of today (April 16, 2025), GILD TTM free cash flow is $10.30 billion, with the most recent change of +$874.00 million (+9.27%) on December 31, 2024.
- Over the past year, GILD TTM FCF has increased by +$874.00 million (+9.27%).
- GILD TTM FCF is now -49.74% below its all-time high of $20.50 billion, reached on December 31, 2015.
Performance
GILD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
GILD Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.9% | -32.1% | +9.3% |
| 3 y3 years | +0.2% | -32.1% | +9.3% |
| 5 y5 years | +30.2% | -32.1% | +9.3% |
GILD Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.9% | -32.1% | +136.7% | at high | +49.4% |
| 5 y | 5-year | at high | +45.9% | -32.1% | +136.7% | -4.6% | +49.4% |
| alltime | all time | -47.2% | +7162.8% | -49.8% | +1952.2% | -49.7% | +6821.7% |
Gilead Sciences Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $10.83B(+45.9%) | $2.83B(-32.1%) | $10.30B(+9.3%) |
| Sep 2024 | - | $4.17B(+248.8%) | $9.43B(+36.8%) |
| Jun 2024 | - | $1.20B(-43.5%) | $6.90B(-12.7%) |
| Mar 2024 | - | $2.11B(+8.2%) | $7.90B(+6.5%) |
| Dec 2023 | $7.42B(-11.1%) | $1.95B(+19.7%) | $7.42B(-5.5%) |
| Sep 2023 | - | $1.63B(-25.7%) | $7.85B(-12.0%) |
| Jun 2023 | - | $2.20B(+34.5%) | $8.93B(+6.4%) |
| Mar 2023 | - | $1.64B(-31.5%) | $8.39B(+0.5%) |
| Dec 2022 | $8.34B(-22.8%) | $2.39B(-11.8%) | $8.34B(-7.4%) |
| Sep 2022 | - | $2.71B(+63.1%) | $9.01B(-4.3%) |
| Jun 2022 | - | $1.66B(+4.1%) | $9.41B(-5.4%) |
| Mar 2022 | - | $1.59B(-47.8%) | $9.95B(-7.9%) |
| Dec 2021 | $10.80B(+43.7%) | $3.05B(-2.1%) | $10.80B(+13.8%) |
| Sep 2021 | - | $3.11B(+41.7%) | $9.49B(+12.0%) |
| Jun 2021 | - | $2.20B(-10.1%) | $8.47B(-2.6%) |
| Mar 2021 | - | $2.44B(+40.9%) | $8.70B(+15.7%) |
| Dec 2020 | $7.52B(-9.6%) | $1.74B(-17.2%) | $7.52B(-7.9%) |
| Sep 2020 | - | $2.10B(-13.5%) | $8.16B(-4.1%) |
| Jun 2020 | - | $2.42B(+91.5%) | $8.51B(+3.2%) |
| Mar 2020 | - | $1.26B(-46.8%) | $8.24B(-0.9%) |
| Dec 2019 | $8.32B(+11.3%) | $2.38B(-2.8%) | $8.32B(+3.5%) |
| Sep 2019 | - | $2.44B(+13.4%) | $8.04B(+5.2%) |
| Jun 2019 | - | $2.16B(+61.0%) | $7.64B(+13.0%) |
| Mar 2019 | - | $1.34B(-36.1%) | $6.76B(-9.6%) |
| Dec 2018 | $7.48B(-33.9%) | $2.10B(+2.5%) | $7.48B(-5.5%) |
| Sep 2018 | - | $2.04B(+60.3%) | $7.91B(-6.2%) |
| Jun 2018 | - | $1.28B(-38.0%) | $8.43B(-20.1%) |
| Mar 2018 | - | $2.06B(-18.8%) | $10.56B(-6.6%) |
| Dec 2017 | $11.31B(-30.6%) | $2.53B(-1.2%) | $11.31B(-6.9%) |
| Sep 2017 | - | $2.56B(-24.6%) | $12.14B(-11.8%) |
| Jun 2017 | - | $3.40B(+21.2%) | $13.78B(-9.1%) |
| Mar 2017 | - | $2.81B(-16.7%) | $15.15B(-7.0%) |
| Dec 2016 | $16.30B(-20.5%) | $3.37B(-19.7%) | $16.30B(-12.2%) |
| Sep 2016 | - | $4.20B(-12.3%) | $18.56B(+2.1%) |
| Jun 2016 | - | $4.78B(+20.9%) | $18.17B(-3.7%) |
| Mar 2016 | - | $3.95B(-29.8%) | $18.88B(-7.9%) |
| Dec 2015 | $20.50B(+67.2%) | $5.63B(+47.7%) | $20.50B(+15.7%) |
| Sep 2015 | - | $3.81B(-30.6%) | $17.73B(-0.6%) |
| Jun 2015 | - | $5.49B(-1.6%) | $17.83B(+8.5%) |
| Mar 2015 | - | $5.58B(+95.4%) | $16.43B(+34.0%) |
| Dec 2014 | $12.26B(+320.6%) | $2.85B(-27.0%) | $12.26B(+21.8%) |
| Sep 2014 | - | $3.91B(-4.5%) | $10.07B(+46.5%) |
| Jun 2014 | - | $4.09B(+191.6%) | $6.87B(+86.4%) |
| Mar 2014 | - | $1.40B(+113.3%) | $3.69B(+26.4%) |
| Dec 2013 | $2.92B(+4.2%) | $658.11M(-8.1%) | $2.92B(+8.2%) |
| Sep 2013 | - | $715.92M(-21.1%) | $2.69B(+1.4%) |
| Jun 2013 | - | $907.73M(+43.3%) | $2.66B(-11.5%) |
| Mar 2013 | - | $633.25M(+45.2%) | $3.00B(+7.3%) |
| Dec 2012 | $2.80B(-20.2%) | $436.19M(-35.7%) | $2.80B(-15.6%) |
| Sep 2012 | - | $678.78M(-45.8%) | $3.31B(-4.4%) |
| Jun 2012 | - | $1.25B(+191.6%) | $3.47B(+10.8%) |
| Mar 2012 | - | $429.77M(-54.9%) | $3.13B(-10.7%) |
| Dec 2011 | $3.51B(+26.5%) | $952.00M(+14.3%) | $3.51B(+7.7%) |
| Sep 2011 | - | $832.82M(-9.1%) | $3.26B(+3.3%) |
| Jun 2011 | - | $916.62M(+13.8%) | $3.15B(+8.0%) |
| Mar 2011 | - | $805.67M(+14.9%) | $2.92B(+5.3%) |
| Dec 2010 | $2.77B(-2.7%) | $701.48M(-3.7%) | $2.77B(-7.6%) |
| Sep 2010 | - | $728.62M(+6.7%) | $3.00B(-3.7%) |
| Jun 2010 | - | $683.03M(+3.7%) | $3.11B(+2.7%) |
| Mar 2010 | - | $658.90M(-29.0%) | $3.03B(+6.4%) |
| Dec 2009 | $2.85B(+40.5%) | $928.29M(+10.2%) | $2.85B(+15.6%) |
| Sep 2009 | - | $842.41M(+39.9%) | $2.46B(+17.2%) |
| Jun 2009 | - | $602.04M(+26.1%) | $2.10B(+9.7%) |
| Mar 2009 | - | $477.26M(-12.1%) | $1.92B(-5.5%) |
| Dec 2008 | $2.03B | $543.10M(+13.0%) | $2.03B(+2.5%) |
| Sep 2008 | - | $480.65M(+15.6%) | $1.98B(+13.9%) |
| Jun 2008 | - | $415.87M(-29.4%) | $1.74B(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $588.76M(+19.5%) | $1.81B(+7.3%) |
| Dec 2007 | $1.69B(+51.6%) | $492.66M(+106.4%) | $1.69B(+2.6%) |
| Sep 2007 | - | $238.70M(-51.3%) | $1.64B(+1.8%) |
| Jun 2007 | - | $489.93M(+5.3%) | $1.61B(+17.8%) |
| Mar 2007 | - | $465.45M(+3.6%) | $1.37B(+23.2%) |
| Dec 2006 | $1.11B(+69.2%) | $449.30M(+114.6%) | $1.11B(+13.4%) |
| Sep 2006 | - | $209.35M(-15.1%) | $981.52M(+58.4%) |
| Jun 2006 | - | $246.57M(+18.8%) | $619.49M(-4.2%) |
| Mar 2006 | - | $207.64M(-34.7%) | $646.98M(-1.6%) |
| Dec 2005 | $657.69M(+44.0%) | $317.97M(-308.2%) | $657.69M(+50.1%) |
| Sep 2005 | - | -$152.69M(-155.7%) | $438.09M(-41.3%) |
| Jun 2005 | - | $274.06M(+25.5%) | $746.51M(+28.2%) |
| Mar 2005 | - | $218.35M(+122.0%) | $582.10M(+27.5%) |
| Dec 2004 | $456.60M(+133.0%) | $98.36M(-36.8%) | $456.60M(-15.8%) |
| Sep 2004 | - | $155.74M(+42.0%) | $542.54M(+66.5%) |
| Jun 2004 | - | $109.65M(+18.1%) | $325.92M(+20.5%) |
| Mar 2004 | - | $92.85M(-49.6%) | $270.58M(+38.1%) |
| Dec 2003 | $196.00M(+245.0%) | $184.30M(-402.7%) | $196.00M(+364.8%) |
| Sep 2003 | - | -$60.88M(-212.1%) | $42.17M(-73.6%) |
| Jun 2003 | - | $54.30M(+197.2%) | $159.56M(+57.6%) |
| Mar 2003 | - | $18.27M(-40.0%) | $101.23M(+78.2%) |
| Dec 2002 | $56.81M(-137.1%) | $30.47M(-46.1%) | $56.81M(-423.7%) |
| Sep 2002 | - | $56.52M(-1502.0%) | -$17.55M(-84.2%) |
| Jun 2002 | - | -$4.03M(-84.6%) | -$110.79M(-24.1%) |
| Mar 2002 | - | -$26.14M(-40.4%) | -$145.95M(-4.8%) |
| Dec 2001 | -$153.31M(+184.8%) | -$43.89M(+19.5%) | -$153.31M(+12.0%) |
| Sep 2001 | - | -$36.72M(-6.3%) | -$136.88M(+18.5%) |
| Jun 2001 | - | -$39.20M(+17.0%) | -$115.52M(+48.0%) |
| Mar 2001 | - | -$33.50M(+22.0%) | -$78.04M(+45.0%) |
| Dec 2000 | -$53.82M(-28.3%) | -$27.45M(+78.7%) | -$53.82M(+33.7%) |
| Sep 2000 | - | -$15.36M(+791.6%) | -$40.27M(-17.2%) |
| Jun 2000 | - | -$1.72M(-81.4%) | -$48.61M(-29.3%) |
| Mar 2000 | - | -$9.28M(-33.2%) | -$68.75M(-8.4%) |
| Dec 1999 | -$75.10M(+20.5%) | -$13.90M(-41.4%) | -$75.10M(-0.9%) |
| Sep 1999 | - | -$23.70M(+8.4%) | -$75.80M(-12.1%) |
| Jun 1999 | - | -$21.87M(+39.9%) | -$86.20M(+22.6%) |
| Mar 1999 | - | -$15.63M(+7.0%) | -$70.33M(+12.9%) |
| Dec 1998 | -$62.30M(-8.8%) | -$14.60M(-57.2%) | -$62.30M(-40.8%) |
| Sep 1998 | - | -$34.10M(+468.3%) | -$105.20M(+30.0%) |
| Jun 1998 | - | -$6.00M(-21.1%) | -$80.90M(+5.6%) |
| Mar 1998 | - | -$7.60M(-86.8%) | -$76.60M(+12.2%) |
| Dec 1997 | -$68.30M(+238.1%) | -$57.50M(+486.7%) | -$68.30M(+658.9%) |
| Sep 1997 | - | -$9.80M(+476.5%) | -$9.00M(-3100.0%) |
| Jun 1997 | - | -$1.70M(-342.9%) | $300.00K(-102.6%) |
| Mar 1997 | - | $700.00K(-61.1%) | -$11.60M(-42.6%) |
| Dec 1996 | -$20.20M(-14.4%) | $1.80M(-460.0%) | -$20.20M(-8.2%) |
| Sep 1996 | - | -$500.00K(-96.3%) | -$22.00M(-19.7%) |
| Jun 1996 | - | -$13.60M(+72.2%) | -$27.40M(+24.5%) |
| Mar 1996 | - | -$7.90M(+33.9%) | -$22.00M(-29.0%) |
| Dec 1995 | -$23.60M(-24.6%) | - | - |
| Sep 1995 | - | -$5.90M(-28.0%) | -$31.00M(+1.3%) |
| Jun 1995 | - | -$8.20M(+6.5%) | -$30.60M(-2.2%) |
| Mar 1995 | - | -$7.70M(-16.3%) | -$31.30M(+2.0%) |
| Mar 1995 | -$31.30M(+22.3%) | - | - |
| Dec 1994 | - | -$9.20M(+67.3%) | -$30.70M(+8.9%) |
| Sep 1994 | - | -$5.50M(-38.2%) | -$28.20M(+3.7%) |
| Jun 1994 | - | -$8.90M(+25.4%) | -$27.20M(+6.3%) |
| Mar 1994 | -$25.60M(+92.5%) | -$7.10M(+6.0%) | -$25.60M(-2.3%) |
| Dec 1993 | - | -$6.70M(+48.9%) | -$26.20M(+12.9%) |
| Sep 1993 | - | -$4.50M(-38.4%) | -$23.20M(+27.5%) |
| Jun 1993 | - | -$7.30M(-5.2%) | -$18.20M(+36.8%) |
| Mar 1993 | -$13.30M(+216.7%) | -$7.70M(+108.1%) | -$13.30M(+137.5%) |
| Dec 1992 | - | -$3.70M(-840.0%) | -$5.60M(+194.7%) |
| Sep 1992 | - | $500.00K(-120.8%) | -$1.90M(-20.8%) |
| Jun 1992 | - | -$2.40M | -$2.40M |
| Mar 1992 | -$4.20M(+55.6%) | - | - |
| Mar 1991 | -$2.70M | - | - |
FAQ
- What is Gilead Sciences annual free cash flow?
- What is the all time high annual FCF for Gilead Sciences?
- What is Gilead Sciences annual FCF year-on-year change?
- What is Gilead Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Gilead Sciences?
- What is Gilead Sciences quarterly FCF year-on-year change?
- What is Gilead Sciences TTM free cash flow?
- What is the all time high TTM FCF for Gilead Sciences?
- What is Gilead Sciences TTM FCF year-on-year change?
What is Gilead Sciences annual free cash flow?
The current annual FCF of GILD is $10.83B
What is the all time high annual FCF for Gilead Sciences?
Gilead Sciences all-time high annual free cash flow is $20.50B
What is Gilead Sciences annual FCF year-on-year change?
Over the past year, GILD annual free cash flow has changed by +$3.41B (+45.91%)
What is Gilead Sciences quarterly free cash flow?
The current quarterly FCF of GILD is $2.83B
What is the all time high quarterly FCF for Gilead Sciences?
Gilead Sciences all-time high quarterly free cash flow is $5.63B
What is Gilead Sciences quarterly FCF year-on-year change?
Over the past year, GILD quarterly free cash flow has changed by -$1.34B (-32.15%)
What is Gilead Sciences TTM free cash flow?
The current TTM FCF of GILD is $10.30B
What is the all time high TTM FCF for Gilead Sciences?
Gilead Sciences all-time high TTM free cash flow is $20.50B
What is Gilead Sciences TTM FCF year-on-year change?
Over the past year, GILD TTM free cash flow has changed by +$874.00M (+9.27%)